Indrayani Biotech

18.83
-0.38
(-1.98%)
Market Cap
85.77 Cr
EPS
1.63
PE Ratio
13.62
Dividend Yield
0.00 %
Industry
FMCG
52 Week High
62.71
52 Week Low
14.05
PB Ratio
1.17
Debt to Equity
1.49
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
364.50
#1 12,657.37
21.52
#1 7,822.10
12.08
#1 598
-4.72
52.07
1,468.10
7,551.77
24.99
1,211.60
7.67
300
34.23
60.10
316.30
7,239.79
16.62
5,481.60
0.44
596
-0.90
70.22
128.41
5,889.79
18.83
5,071.40
1.77
346
-29.17
67.98
330.40
1,982.40
31.42
1,345.00
-3.39
61
-12.90
69.59
98.29
1,791.28
27.19
1,081.70
-10.58
67
#1 63.37
58.13
336.20
1,671.78
17.21
1,365.20
-2.40
116
-25.06
64.57
205.26
1,280.22
52.61
1,390.20
#1 17.14
18
47.83
61.55
62.00
944.16
21.48
529.80
-9.36
53
-3.57
56.36
220.62
689.31
#1 14.17
1,385.00
-4.46
50
-32.50
63.62
Growth Rate
Revenue Growth
-
Net Income Growth
-12.61 %
Cash Flow Change
-287.46 %
ROE
-44.59 %
ROCE
-33.65 %
EBITDA Margin (Avg.)
13.57 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
14
4
5
6
7
14
15
15
17
26
44
46
51
42
41
39
45
32
31
17
Expenses
14
9
4
7
10
13
13
13
15
23
37
41
46
40
33
36
34
28
26
14
EBITDA
1
-5
1
-1
-2
1
2
2
2
3
7
5
5
3
7
4
11
4
5
3
Operating Profit %
6 %
-159 %
13 %
-20 %
-36 %
7 %
11 %
12 %
13 %
12 %
12 %
12 %
6 %
6 %
18 %
9 %
23 %
13 %
17 %
17 %
Depreciation
0
0
0
0
-0
0
0
0
0
1
1
1
1
1
1
1
1
1
3
2
Interest
0
0
0
0
1
0
1
1
0
1
1
1
2
2
1
1
6
2
1
1
Profit Before Tax
0
-5
0
-2
-3
1
1
1
2
2
5
3
2
-0
6
1
5
1
1
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
-5
0
-2
-3
1
1
1
2
2
5
3
1
-0
6
1
5
1
1
0
EPS in ₹
0.08
-1.57
0.03
-0.51
-0.92
0.20
0.30
0.33
0.47
0.52
1.47
0.72
0.32
-0.06
0.89
0.22
0.58
0.10
0.13
0.05

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
Total Assets
52
40
51
156
235
Fixed Assets
17
15
17
58
62
Current Assets
19
9
19
78
145
Capital Work in Progress
14
14
13
14
20
Investments
0
0
0
0
0
Other Assets
21
11
22
85
152
Total Liabilities
52
40
51
156
235
Current Liabilities
14
12
20
72
87
Non Current Liabilities
7
8
7
36
72
Total Equity
31
20
25
48
76
Reserve & Surplus
-3
-15
-10
10
18
Share Capital
4
34
34
44
46

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
1
-1
1
2
-3
Investing Activities
-4
-1
-1
-47
-16
Operating Activities
6
0
4
16
-30
Financing Activities
-1
-0
-3
33
44

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
50.39 %
50.39 %
50.39 %
50.17 %
48.81 %
44.91 %
44.89 %
44.89 %
44.89 %
44.89 %
44.84 %
33.63 %
42.13 %
33.57 %
33.48 %
33.40 %
33.28 %
33.28 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
22.04 %
22.04 %
22.04 %
22.04 %
22.04 %
22.04 %
19.17 %
17.16 %
17.03 %
15.27 %
13.11 %
0.00 %
8.47 %
6.75 %
6.79 %
5.59 %
5.25 %
3.66 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.34 %
22.95 %
23.45 %
24.09 %
27.20 %
27.05 %
29.25 %
30.78 %
30.80 %
31.93 %
35.44 %
53.28 %
44.33 %
55.78 %
43.63 %
45.86 %
46.37 %
46.64 %
Others
6.22 %
4.62 %
4.11 %
3.70 %
1.95 %
5.99 %
6.69 %
7.17 %
7.29 %
7.90 %
6.61 %
13.09 %
5.07 %
3.90 %
16.09 %
15.16 %
15.10 %
16.42 %
No of Share Holders
0
18,926
20,362
20,201
20,817
20,925
20,914
22,049
22,112
22,435
22,590
23,034
23,914
23,958
24,132
24,419
25,254
25,126

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Raising of FundsApr 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 05, 2025
Announcement under Regulation 30 (LODR)-Raising of FundsApr 03, 2025
Announcement under Regulation 30 (LODR)-Raising of FundsApr 03, 2025
Appointment Of Dhinakaran Rajagopal As Chief Financial Officer (CFO) Of The CompanyApr 03, 2025
Appointment Of Dhinakaran Rajagopal As Chief Financial Officer (CFO) Of The CompanyApr 03, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Apr 03, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Apr 03, 2025
Outcome Of Board Meeting Held On 3Rd April 2025Apr 03, 2025
Outcome Of Board Meeting Held On 3Rd April 2025Apr 03, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd April 2024Apr 03, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd April 2024Apr 03, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 01, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 01, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 01, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 01, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 01, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 01, 2025
Board Meeting Intimation for Considering And Amending The Terms Of Rights Issue Of Equity SharesMar 27, 2025
Closure of Trading WindowMar 26, 2025
Clarification On Consolidated Financial Results Submitted For The Quarter Ended December 31 2025Mar 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 01, 2025
Company PresentationMar 01, 2025
Results-Delay in Financial ResultsFeb 28, 2025
Results-Delay in Financial ResultsFeb 28, 2025
Integrated Filing (Financial)Feb 27, 2025
Integrated Filing (Financial)Feb 27, 2025
Financial Results For The Quarter And Nine Months Ended 31 December 2024Feb 27, 2025
Financial Results For The Quarter And Nine Months Ended 31 December 2024Feb 27, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended 31-12-2024Feb 26, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended 31-12-2024Feb 26, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesFeb 14, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results(Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended 31-12-2024Feb 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 20, 2025
Announcement under Regulation 30 (LODR)-Change in RTAJan 02, 2025
Closure of Trading WindowDec 28, 2024
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.Dec 17, 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Dec 17, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Announcement under Regulation 30 (LODR)-Raising of FundsNov 15, 2024
.Pursuant To Regulation 33 Of SEBI (LODR) Regulations 2015, The Board Of Directors Meeting Held On Today I.E, 14-11-2024 Has Approved The Unaudited Standalone And Consolidated Results For The Quarter Ended 30-09-2024.Nov 15, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14-08-2024 Is Attached.Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14-08-2024 Is Attached.Nov 14, 2024
Board Meeting Intimation for The Approval Of Unaudited Financial Results Of The Company And Rights Issue Of Equity SharesNov 11, 2024
Announcement Under Regulation 30 - Clarification Regarding Significant Movement In PriceNov 05, 2024
Clarification sought from Indrayani Biotech LtdNov 04, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 10, 2024
Closure of Trading WindowSep 28, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 24, 2024

Technical Indicators

RSI(14)
Neutral
47.79
ATR(14)
Less Volatile
0.85
STOCH(9,6)
Neutral
66.51
STOCH RSI(14)
Neutral
79.72
MACD(12,26)
Bullish
0.44
ADX(14)
Weak Trend
24.42
UO(9)
Bearish
45.79
ROC(12)
Uptrend But Slowing Down
14.19
WillR(14)
Neutral
-32.98